This article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and education use, including for instruction at the authors institution and sharing with colleagues.
Introduction
Asbestos is a family of naturally occurring fibrous materials (IOM/NRC, 2009; Lippmann, 2009 ) historically used as fire retardants, for insulation, and as a filler to strengthen other materials such as cement products used in building materials and potable water supply systems. Because some kinds of asbestos are composed of very durable, thin fibers, they are very effective for these uses. However, certain of the fibers are highly respirable and some forms (i.e., amphibole asbestos, e.g., amosite, crocidolite) can persist almost indefinitely in the lung. Thus, inhalation exposure to certain types of asbestos fibers such as amphibole asbestos can result in chronic lung inflammation, asbestosis (a fibrotic lung disease), lung cancer and mesothelioma (ATSDR, 2001; Lippmann, 2009) . Some forms of asbestos (e.g., chrysotile) are less persistent in the lung and appear to be much less toxic. The adverse effects of amphibole asbestos are delayed, not manifesting for 10-40 years following inhalation exposure. Thus, for many years, the toxic nature and, especially, the carcinogenic potential of amphibole asbestos was not recognized or well understood. Moreover, because the asbestos containing materials were so effective in a wide range of product applications, many kinds of asbestos containing products were widely used around the world.
Another group of fibers also used for insulation and for other purposes are synthetic vitreous fibers (SVFs). The SVFs are also referred to as man-made vitreous fibers (MMVF) or simply as glass fibers. These synthetic fibers in some cases were used as replacements for various asbestos products. SVFs include inorganic fibrous substances with an amorphous (vitreous, i.e., non-crystalline) molecular structure (Hesterberg and Hart, 2001) . SVFs can be divided into four general categories: (a) glass fibers (including glass wool and the thicker glass filament), (b) special purpose fibers, (c) mineral wools (rock, stone, and slag wools), and (d) refractory ceramic fibers. The four categories of SVFs vary greatly in their toxicity and potential for causing cancer and other diseases as will be discussed in this paper. Moreover, the composition and manufacturing processes used to produce synthetic fibers can be varied 0273-2300/$ -see front matter Ó 2012 Elsevier Inc. All rights reserved. doi:10.1016/j.yrtph.2012. 01.002 to alter the characteristics of the fibers enhancing their desirable properties and, as will be discussed later, minimizing their potential for posing a health hazard.
Knowledge that exposure to certain kinds of asbestos was associated with increased occurrence of lung disease and, especially, the development of mesothelioma which is a rare cancer triggered a large number of personal injury lawsuits. The Johns-Manville (J-M) Company, which had emerged as the world's leading manufacturer of asbestos-containing products, was a defendant in many personal injury lawsuits brought by asbestos exposed workers. The plaintiffs prevailed in numerous cases and were awarded substantial amounts of damages from J-M and other defendants. By 1982 J-M determined that its projected financial liabilities, driven by the increase in the number of claims and the ultimate amount of damages, would eventually exceed its assets. But it was also apparent that J-M had substantial operating assets that did not involve asbestos products and that those assets had the potential for serving as the core of an economically viable company that could continue in business if the asbestos product lines were discontinued. These factors led to the decision by J-M in 1982 to enter Chapter 11 bankruptcy reorganization (Johns Manville, 2010) .
As part of the overall reorganization effort, a new company, Manville Corporation (Manville) was formed. J-M's asbestos assets were sold to third parties while J-M's non-asbestos assets were transferred to Manville for continuing operation. J-M's asbestos liabilities were transferred to the Manville Personal Injury Settlement Trust (PI Trust) or the Manville Property Damage Trust (PD Trust). The PI Trust was funded largely with J-M insurance proceeds and 80% ownership in the new Manville, which was to be operated for the benefit of asbestos victims (Manville Trust, 2011) .
Under the terms of the reorganization plan, J-M's commercial debtors were to be paid in full by Manville and asbestos victims would receive payment from the PI Trust or PD Trust based on the severity of their illness or the nature of the property damage. J-M's previous shareholders lost as much as 98% of their equity.
In order for those suffering from asbestos-related diseases to be compensated by the Trust, Manville would have to be profitable. Accordingly, the building materials part of Manville, turned to synthetic glass fibers to make its insulation products and other special products. Among the various non-asbestos products of Manville, it was apparent that its synthetic glass fiber production and sales would be key to Manville's future long-term survival as a profitable company. In 1997, Manville changed its name to the current Johns Manville. The PD Trust was dissolved in the 1990s and in 2001, the PI Trust sold its stake in Manville to Berkshire Hathaway.
It is important to recognize that other companies with product lines that included both asbestos and vitreous fibers were in a similar situation. Indeed, some of those companies also became bankrupt. Essentially all of them had major reorganizations. Thus, what is recounted in this paper from the perspective of Manville is also the saga of other companies with similar product lines. Many of these companies shared in the financial support of much of the research recounted here primarily working through their trade associations. Initially, industries primary trade association with the Thermal Insulation Manufacturers Association and, later the North American Insulation Manufacturers Association. The scientific staff of many of those companies were also valuable contributors to the planning and review of much of this research reviewed in this paper.
Are glass fiber products safe?
Throughout this paper the words safe and hazardous are used repeatedly. Safe and hazardous are relative terms at opposite ends of a spectrum. A safe product is a product that when used in accordance with the producer's recommendations and contemporary practices has a vanishingly low probability of causing harm. A hazardous product is one that has the potential to cause harm unless special steps are taken over and above usual consumer or workplace practices to avoid harm to the user. This paper is in a sense a saga of creating a body of scientific knowledge that allows the marketing and use of safe man-made glass fiber products.
Shortly before it emerged from its bankruptcy reorganization, J-M faced a second potential product liability crisis -the safety of its glass fiber products that would test its commitment to ethical behavior. The potential safety issue arose over whether glass fiber would be the ''next asbestos,'' indeed, would synthetic glass fiber be viewed as ''man-made asbestos?'' In the minds of regulators and the public, there was concern that exposure to fiber glass, because of its fibrous nature, like asbestos, might cause lung disease. In the minds of company management, ''the next asbestos'' had a different connotation. In the absence of clear and definitive information on the potential health hazards of glass fiber, and in light of J-M's tarnished reputation, the Company's products might be shunned in the marketplace -driving the company out of profitability and possibly into a second bankruptcy (Sells, 1994) . In the absence of a viable fiber glass business the company would probably have had to liquidate its assets.
The harbinger of the product liability concern was a symposium on synthetic vitreous fibers (SVFs) held in Copenhagen in October of 1986 under the auspices of the World Health Organization (WHO, 1986) . The symposium was held to review progress in research on the toxicity of all kinds of SVFs, including much of the research that had been sponsored by J-M and other SVF manufacturers. The symposium also served to provide an update on information the International Agency for Research on Cancer (IARC) would use to prepare the next Monograph on the carcinogenic risks to humans of man-made vitreous fibers (IARC, 1988) . In an overview and summary of the symposium, world-renowned epidemiologist Sir Richard Doll made this cautious statement, ''If I now abandon the firm basis of scientific judgment. . .I do so because I know that in the absence of such a conclusion, many people may think that the whole symposium has been a waste of time. Let me therefore add. . . accepting that [fiber glass and other synthetic vitreous fibers] are not more carcinogenic than asbestos fibers, we can conclude that exposure to fiber levels on the order of 0.2 respirable fibers per [cubic centimeter] is unlikely to produce a measurable risk even after another 20 years have passed'' (Doll, 1987) Doll's recommendation of a 0.2 fiber/cc was the same as the asbestos personal exposure limit in place in the United States at that time. While couching his recommendation in tentative language, Doll had in effect equated fiber glass and asbestos fibers.
Based on worker health data, the scientific community generally agreed that fiber glass, if it was hazardous to health, was substantially less so than chrysotile asbestos (Doll, 1987) . However, the mandate of regulatory agencies is to protect workers and the public. In the absence of compelling evidence to the contrary, these agencies had little choice but to assume that a substance is harmful. Unfortunately, such a decision has two potential adverse consequences. First, declaring a product hazardous may result in consumers preferring competing products -even those that have not been tested at all and may actually be hazardous. Second, consumers may develop ''hazard fatigue.'' When told that many products are hazardous, consumers may be overwhelmed by the information and become fatalistic, giving little credence to any warning. The view of the authors was that Manville's best strategy was to conduct research that would provide compelling evidence that products are safe to manufacture and use when appropriate workplace and use practices are followed. This strategy also recognized the potential for identifying products that had a hazard potential that would require special approaches to ensure the safety of workers and consumers.
When Doll made his 0.2 fiber/cc recommendation in 1986 for control of exposures to vitreous fibers, a general understanding was beginning to emerge that less biopersistant fibers, as measured by how quickly the fibers dissolve in a simulated body fluid, were less toxic than highly biopersistent fibers such as amphibole asbestos. However, it was not known if a biopersistance threshold existed below which exposure to biosoluble fibers was certain to not cause lung disease, regardless of dose, dimension or solubility. In the absence of such a threshold, Doll (1987) and (later) various hazard identification and regulatory agencies, defaulted to recommending that fiber glass exposure be limited to the then-current asbestos standard. It is important to recognize that during that era momentum was also growing to not just limit exposure to asbestos but to ban the manufacture and use of asbestos products based on the fact it was a known human carcinogen.
It was apparent to the companies manufacturing and marketing glass fiber products, and most certainly to J-M, that their already substantial product stewardship program for glass fibers would need to be expanded and accelerated. That expanded program included continuation of epidemiological studies of fiber glass workers, establishment of stringent workplace exposure limits, and development and implementation of a research program to evaluate the safety of existing fiber glass products and guide the development of new products. These activities were conducted with scientific oversight by industry scientists and external scientific consultants. Moreover, regulatory authorities were kept informed of the research program and provided the opportunity to comment on protocols before research was initiated. From the beginning, it was agreed that the research findings would be presented at scientific meetings and published in peer reviewed journals.
State of the science -1987
As background for considering the new activities of the reorganized J-M Company and other fiber glass manufacturers, it is appropriate to consider in some detail the state of the science on the toxicity and carcinogenicity of the various man-made vitreous fibers as it existed in 1987. As will be discussed later, IARC in 1987 used the available science to conduct the first in-depth, independent evaluation of the human carcinogenic potential for fiber glass with the results of the evaluation published the following year (IARC, 1988) . Moreover, an understanding of the state of the science in 1987 provides insight into how the knowledge base on the toxicity and carcinogenicity of glass fibers could be improved. (pre-1987) Beginning in 1975, J-M, in cooperation with other manufacturers of fiber glass, contracted with researchers at the University of Pittsburgh, Graduate School of Public Health, Department of Biostatistics to conduct a historical cohort study of production and maintenance workers at 17 of the oldest and largest fiber glass and mineral wool manufacturing facilities in the United States (Marsh and Enterline, 1977) . The main objective of the study was to evaluate total and cause-specific mortality risks among those workers, with primary emphasis on any possible association between fiber exposure and malignant or non-malignant respiratory disease deaths. The focus of the study was manufacturing where exposure to glass fibers was viewed as being the highest and certainly much higher than that of users of fiber products. There was a companion study conducted by other researchers (Esmen et al., 1979) at the University of Pittsburgh to estimate historical workplace fiber exposures. The initial study mainly followed the mortality from 1946 through 1977 of 16,661 SVF workers employed one year or more during 1940 -1963 (Enterline and Marsh, 1981 . The study was updated for the period from 1978 through 1982 and expanded to include a case-referent study to investigate the possible role of smoking as a confounder biasing the study results (Enterline et al., 1987) . Results from the updated study were presented at the WHO Symposium in Copenhagen in 1986 and may have influenced Sir Richard Doll's 0.2 fiber/cc recommendation. Enterline et al. (1987) , whose research had been funded by the fiberglass industry, reported the 1946-1982 mortality death rates for workers compared to expected deaths noting there was a statistically significant increase in all malignant neoplasms as a category and in lung cancer 20 or more years after first employment. For respiratory cancers the excess was greatest for mineral wool workers. For glass wool workers and glass filament workers, the respiratory cancer rates were much lower. There were few positive relationships between respiratory cancer Standardized Mortality Ratio (SMR) and duration of exposure, time since first exposure or measures of fiber exposures. In a case-referent study, which controlled for smoking, there was a statistically significant relationship between fiber exposure and respiratory cancer for mineral wool workers but not for fiber glass workers.
Epidemiology studies
While the University of Pittsburgh cohort mortality studies were underway, researchers at Tulane University, with support from the insulating materials manufacturers, were conducting cross-sectional and follow-up surveys of the respiratory health of employees of seven of the manufacturing plants included in the mortality study (Weill et al., 1983; Hughes et al., 1993) .
A 1979-1980 survey of the respiratory health of 1028 male production workers included respiratory questionnaires, tests of lung function and readings of chest radiographs in relation to indices of exposure to man-made vitreous fibers (MMVF). Weill et al. (1983) reported, ''The study population was found to be generally healthy, with respiratory symptoms not related to fiber exposure and no detected adverse lung function consequences of that exposure.'' Furthermore, it was concluded that ''exposure to MMVF with small diameters may lead to low-level profusion of small opacities. However, without high-level profusion of these opacities in a population with a considerable range of exposure durations, a diffuse tissue reaction (e.g., fibrosis) seems unlikely but cannot be excluded.'' 3.2. Laboratory animal studies using implantation (pre-1987) Prior to 1987, laboratory research on the health effects of fiber glass and other inorganic fibers consisted primarily of studies in which fibers were placed into the pleural and peritoneal cavities of rats (Pott and Friedrichs, 1972; Stanton and Wrench, 1972; Stanton et al., 1977 Stanton et al., , 1981 as an alternative to conducting studies using inhalation exposure. The motivation for conducting those early studies was largely based on concern for understanding the comparative effects of various kinds of asbestos fibers and a desire to understand which of the fiber characteristics, especially diameter and length, were responsible for asbestos-induced disease. In those studies, fibers of various compositions and sizes were injected or implanted into the peritoneal cavity (abdominal intraperitoneal (IP) injection), the space between the chest wall and the lung surface (pleural space), or instilled into the trachea using a syringe (intratracheal instillation (IT)). The quantities of material injected or implanted were quite large, for example, Stanton et al. (1977 Stanton et al. ( , 1981 used a standard dose of 40 mg in gelatin pledgets for implantation into the pleural cavity. The 40 mg of test material would correspond to placing about 11 g of fibrous material into the thoracic cavity of a 70 kg person. To provide perspective, a crocidolite asbestos aerosol used in inhalation exposure studies with rats, to be described later, contained 6.3 Â 10 8 fibers/m 3 when normalized to 1 mg/m 3 (Hesterberg et al., 1996a . Thus, 40 mg of this material would only contain 4.6 Â 10 8 fibers. Over 70% of the fibers were over 5 lm in length and more than one-fourth were over 20 lm in length. It is readily apparent that the quantities of fibers implanted were much greater than the quantities a rat could inhale during a two-year bioassay.
Many, but not all, of the implantation and injection studies reported an excess of tumors (most of which were diagnosed histopathologically as sarcomas) in rats in the asbestos-treated groups following these types of implantation exposure as well as in some glass fiber treated groups. However, it is noteworthy that 43 out of 72 materials tested by Stanton et al. (1977 Stanton et al. ( , 1981 did not yield a statistically significant increase in tumors. This included 16 different glass fiber preparations. Interpretation of the results of the early studies focused on the congruence between the findings of intra-cavity studies and the emerging epidemiological findings in asbestos-exposed workers. Limited attention was given to the glass fiber groups which did not show an excess of tumors despite being administered large quantities of glass fibers. In short, the intra-cavity study findings provided a basis for interpreting the importance of fiber dimensions (especially long and thin fibers) in the pathogenesis of asbestos-induced fibrosis (asbestosis), lung cancer and mesothelioma.
3.3. Cell studies (pre-1987) In the 1980's, numerous laboratories in the US and other countries were studying the toxicity of various kinds of asbestos fibers and other fibers in vitro, that is, in cultured cells. Cells were extracted from the tissues of laboratory animals and grown in culture dishes. Some cells were treated with chemicals to enhance their longevity and proliferation in culture and the ability to produce serial cultures. Other cultures were primary cells that were taken directly from the animal and, in general, were more difficult to grow in culture.
As may be recalled, the 1970s and 1980s were a period of major advances in cell and molecular biology. There was growing enthusiasm for using the emerging new techniques for detecting alterations in cells caused by toxic agents and for using the new approaches to screen new agents for toxic effects. The National Institute of Environmental Health Science (NIEHS) devoted substantial resources, both within their intramural and extramural research program, to advance the use of cellular and molecular approaches to studying genotoxic effects. One of us (TWH) was at the NIEHS in the early 1980s as a Postdoctoral Fellow at that time in the laboratory of J.C. Barrett, a well-known cell and molecular biologist, and participated in research on chromosomal mutations and cell transformation in mammalian cells treated with asbestos fibers and other mineral dusts (Barrett et al., 1983 Hesterberg and Barrett, 1984, 1985; Hesterberg et al., , 1986 Oshimura et al., 1984 Oshimura et al., , 1986 .
At the time the members of the research team were optimistic that the results of in vitro studies could identify key events induced by asbestos fibers that were responsible for the carcinogenic effects observed in workers exposed to asbestos. It was easy to envision that the in vitro mutagenicity assays could be used to screen man-made fibers currently being used or being considered for introduction to the market place. Short-term assays, such as the well-known Ames test (Ames et al., 1973) were being greeted with enthusiasm as an approach to identifying chemicals that were mutagens, and presumed to be carcinogens. In retrospect, some of the in vitro research findings were possibly over-interpreted. There is no question based on today's knowledge that the quantities of asbestos fibers used in many of the in vitro cell studies were massive when compared to the likelihood of cells encountering one or several fibers following inhalation exposure. It is also apparent now that the design of the studies could have been improved if a substantially broader range of exposure (dose) concentrations had been studied and greater effort had been expended in linking the dose used in the in vitro studies to in vivo doses actually encountered by tissues following exposure of people or laboratory animals to airborne fibers. However, the focus of the research was primarily on demonstrating and studying effects at the cellular level, not on understanding exposure (dose)-response relationships. In the absence of that kind of hindsight, it seemed reasonable in the 1980s to use the methods that had proved successful with various kinds of asbestos fibers to study synthetic fibers. In short, would similar signature effects be observed when cells were administered synthetic fibers? 3.4. Inhalation studies with glass fibers (pre-1987) It is important to place a review of pre-1987 inhalation toxicity studies in experimental animals with glass fibers in context relative to the overall development of aerosol science and inhalation toxicology methods for studying all kinds of airborne materials. Relatively few inhalation studies with laboratory animals had been conducted pre-World War II and these were typically with gases and of short duration. The United States Manhattan Project, with a goal of developing an ''atomic bomb,'' brought with it concern for a wide range of airborne particulate materials whose chemical and/or radiological properties suggested they might pose an inhalation hazard.
Thus, an important component of the Manhattan Project was the development of methods for generating and characterizing airborne particulate material and for conducting inhalation toxicity studies. Much of this work was conducted during and after WW II at the University of Rochester (U of R), post-WWII at the Hanford Laboratories (which became the Pacific Northwest Laboratories in 1966) in Richland, WA and, later at the Lovelace organization in Albuquerque, NM. Sidney Laskin, a key scientific contributor to the U of R effect would later play a key role in developing extensive inhalation toxicology capabilities at New York University.
In the 1960s, a few laboratories began developing the capabilities for conducting lifespan duration inhalation studies with airborne particulate material in rodents. Four laboratories that were at the forefront of this effort were the Lovelace organization, the Pacific Northwest Laboratories (operated by the Battelle Memorial Institute beginning in 1965), the Fraunhofer Laboratory in Hanover, Germany and the Battelle Memorial Institute in Geneva, Switzerland. Two other laboratories conducted a few lifespan duration inhalation studies with airborne particulate material; the Battelle Memorial Institute Laboratories at Columbus, OH and the Los Alamos National Laboratory at Los Alamos, NM. Ironically, the National Institute of Environmental Sciences, including the National Toxicology Program, never developed a sustained in-house capability for conducting lifespan duration studies in rodents with airborne particulate material and, instead, contracted with the Pacific Northwest and Lovelace organization to conduct such studies. With this as background, it is not surprising that few long-term inhalation exposure studies with synthetic glass fibers had been conducted prior to 1987.
Two sets of inhalation toxicity studies with glass fibers conducted in the early 1980s are of special note. One set was conducted at the Battelle Memorial Institute's Columbus, OH laboratory and the second set was conducted at the Los Alamos National Laboratory (LANL) facility in Los Alamos, NM. The Battelle studies were conducted for the National Institute of Occupational Safety and Health (NIOSH), the results were detailed in a comprehensive report by Mitchell et al. (1982) and summary publications by Mitchell et al. (1986) and Moorman et al. (1988) . These studies involved inhalation exposures of rats and monkeys to Tempstran Code 100/475 glass fibers without binder and Owens-Corning FM series air-filter media with binder. It is noteworthy that the studies conducted by Mitchell et al. (1982) and reported by Mitchell et al. (1986) and Moorman et al. (1988) did not identify an excess of respiratory tract tumors in the rats exposed to fiber glass.
The LANL set of inhalation studies were conducted in the early 1980s with industry support. The results were reported by Smith et al. (1987) at the 1986 WHO Copenhagen Meeting. The LANL studies were noteworthy in that they used newly developed technology for conducting nose-only exposures as contrasted to the traditional approach of exposing animals group-housed in chambers. Previously, nose-only exposures were typically used for single or a few brief exposures.
In the LANL study, six different fiber types were evaluated (four of fiber glass, one of refractory ceramic fiber (RCF), and one of mineral wool fiber) in rats and hamsters. The fibers used were not size selected by length and diameter in advance. Instead the fibers were ground to try to produce a finer aerosol that would be readily inhalable by rodents. This resulted in many of the exposure aerosols having few if any fibers longer than 20 lm in length (the length that has the greatest pathogenicity due to the inability of the macrophage to fully phagocytise and clear such a fiber). In those studies, none of the four types of fiber glass or the mineral wool fiber that were tested caused cancer. However, in the RCF exposure group, one lung mesothelioma was observed in a hamster; it was deemed to not be statistically significant. However, some scientists viewed it as a harbinger of what might be observed if the study were repeated with more animals or in a different species. The statistically negative results in the Los Alamos study were also questioned by some observers, because the individual fibers in the exposure aerosol were on average shorter than the lengths of fibers typically found in workplace air. This probably occurred as a result of the aerosol generation process, a Timbrell generator that was used to generate the aerosol in the study. The Los Alamos difficulties in generating an appropriate aerosol of long fibers served as a stimulus for developing an improved system that was used in later studies. It is now well known that fiber length is an important determinant of fiber pathogenicity.
Ironically, neither the Battelle-Columbus nor the LANL maintained a long-term capability for conducting lifespan duration inhalation exposure studies with particulate materials. This makes it difficult to place the results of the studies cited above in context relative to the results of multiple studies conducted in the same laboratory with a common protocol as will be described later.
At this juncture, it is appropriate to consider how the epidemiological and laboratory animal data on glass fibers were being used in 1987 to evaluate potential human hazard.
4. Carcinogen classification schemes and use of old science 4.1. IARC carcinogenic hazard evaluation (1987) (1988) The first in-depth and independent evaluation of the carcinogenic potential of fiber glass was conducted by International Agency for Research on Cancer (IARC) in 1987 and reported the following year (IARC, 1988) . The evaluation of glass fibers was part of the IARC international, interdisciplinary monograph program developed by IARC (1972) to identify the carcinogenic hazards to humans from a wide range of agents and exposure conditions. The IARC reviews are conducted by Working Groups of international scientists selected by the Agency for their knowledge of the agents and/or exposures being evaluated and to provide international representation. The results of the reviews are reported in IARC monographs that deal with the findings for a specific agent or condition of human exposure or a series of related agents or exposure conditions. Each IARC Monograph evaluation for an agent or exposure condition is based on the Working Group's extensive review and critical analysis of the published peer-reviewed scientific literature relevant to evaluating the carcinogenic properties of the agent or exposure. The Working Group evaluations focus on the strength of the total evidence for carcinogenicity to humans and laboratory animals. The IARC classification evaluations places an agent or exposure condition in one of five groups by combining evidence for cancer in exposed humans with empirical evidence for carcinogenicity in laboratory animals and supporting data (see Table 1 ). There is no external review process for the IARC monographs.
The results of the IARC (1988) Monograph evaluation of manmade fibers are summarized in Table 2 . In this evaluation, the results of intraperitoneal (IP) injection studies in laboratory animals were given substantial weight. The results of inhalation studies did not play a major role in the review because the few inhalation studies that had been conducted pre-1987 were few in number and had not been designed nor conducted to the rigorous standards that would be introduced later. As may be noted in Table 2 , the IARC (1988) Monograph categorized man-made fibers into five separate categories.
By way of comparison, IARC (1973, 1977, 1987) classified six forms of asbestos (actinolite, amosite, anthophyllite, chrysotile, crocidolite, and tremolite) as ''carcinogenic in humans'' (Group 1) based on ''sufficient human evidence.'' Since the synthetic fibers were evaluated by some of the same experts that evaluated in 1987 the several kinds of asbestos, it is reasonable to speculate the findings with the several kinds of asbestos, and especially the weight given to the intra-cavitary test results for both asbestos and man-made fibers, may have influenced the interpretation of the significance of the intra-cavitary study results as predictors of the carcinogenicity of synthetic fibers.
National Toxicology Program report on carcinogens classification
The National Toxicology Program (NTP), an organization within the US Department of Health and Human Services, among its multiple responsibilities is charged with identifying carcinogenic hazards of various materials under a 1978 Congressional mandate. The NTP discharges this responsibility by periodically publishing a ''Report on Carcinogens'' with the first one issued in 1980 (NTP, 1980) . The process used by the NTP differs from that used by IARC and has evolved over the years. The current approach is well documented (NTP, 2009a,d) and illustrated in Fig. 1 . As an initial step, a Background Document is prepared using the scientific information available on a particular chemical or material. Typically, this Background Document is prepared by a contractor to the NTP, as contrasted to the IARC reports which are prepared by participating scientists with the assistance of the IARC staff. The NTP Background Documents are made available for public comment and review by panels of expert scientists appointed by NTP. The NTP classification scheme used to compile the Reports is basically a two-bin system with agents classified as either ''known human carcinogen'' or ''reasonably anticipated to be a human carcinogen.'' This contrasts with the five category scheme of IARC.
In preparing recent reports, the NTP has appointed Expert Panels of scientists knowledgeable of the scientific information available to offer advice on the adequacy of the review of background information and on listing/delisting of the substance under review. The NTP Expert Panel's recommendations usually carry substantial weight. However, the report and the Panel's recommendations are subjected to further review and endorsement (or rejection) by two review groups of government scientists and officials before being finalized. The first of these is the Interagency Scientific Review Group (ISRG) and the second is the NIEHS/NTP Scientific Review Group (NSRG). Both of these Groups, consisting of government employees, meet in closed sessions and recommend a listing status, a human carcinogen, reasonably anticipated to be a human carcinogen or not listed. In an additional step, the NTP's Board of Scientific Counselors review and comment on the documentation and listings. The NTP staff and Director then make a final decision on listing or not listing the agent in the next NTP Report on Carcinogens. The potential also exists for a decision to delist a chemical or material that was previously listed. If an agent is listed, brief documentation is prepared for publication in the RoC summarizing the rationale for the decision. At a final stage, the Report is reviewed and approved for release by the Secretary of the The preparation of the 7th Report on Carcinogens was carried out by government scientists with review by the Board of Scientific Counselors. It did not involve a special Panel of experts as will be noted for preparation of the 12th Report on Carcinogens as will be discussed later. Recall that at the time the 7th Report on Carcinogens was being prepared, the findings from the substantial industry research program were just beginning to appear in the peer-reviewed literature. The insulation glass wool fiber industry had argued during the listing process for the 7th RoC that the listing criteria were based on obsolete science and on a classification scheme that equates the IARC ''possibly carcinogenic'' with the NTP's ''reasonably anticipated to be a carcinogen.'' The industry commenters did not prevail. The Secretary of Health and Human Services responded that this listing ''is... descriptive and represents the initial step in hazard identification... It is necessary to conduct a risk assessment in order to estimate the potential for any substance to harm human health.'' (NTP, 1994.)
Multi-faceted path forward in 1987
The IARC (1988) evaluation of man-made vitreous fibers made clear the importance of having epidemiological evidence available on the various types of man-made fibers irrespective of whether the results did or did not show an association between exposure and increased cancer risk. Thus, it was apparent that extension of the previous epidemiological studies on workers occupationally exposed to glass fibers would be an important element of any on-going product stewardship program for man-made fibers. The results of this effort are described later.
The IARC review (1988) also demonstrated that the results of studies conducted in experimental animals, even with inadequate epidemiological evidence (a term used even if epidemiological studies have been conducted and do not show a statistically significant association) could be used to place a specific fiber in Category 2b, ''possibly carcinogenic to humans.'' The IARC review also demonstrated that in the absence of well-conducted studies using inhalation exposure, the normal physiological mode of intake of airborne fibers, the Review Panel would use data from intra-cavitary implantation or injection studies as positive evidence. It was apparent in the mid-1980s that some researchers were likely to continue to conduct intra-cavitary implantation or injection studies especially because of the ease with which they could be conducted. Thus, it was clear that chronic inhalation studies using contemporary aerosol science and inhalation toxicology methods would need to be at the core of any future product stewardship research efforts to evaluate the safety of various types of glass fibers and that such studies were unlikely to be conducted without industry support. This program will be described in a later section. As the inhalation toxicology effort with man-made glass fibers progressed, it became apparent that substantial attention would need to be given to understanding the role of biopersistence as a major factor influencing the toxicity and, especially, carcinogenicity of airborne fibers. The research conducted pre-1987 using cellular assays provided a rationale for conducting additional studies using this approach as will be discussed later.
Epidemiological studies (post-1987)
The epidemiology studies, that were underway in 1987 with sponsorship from the insulation material manufacturers, were continued and eventually examined the mortality of an enlarged cohort of over 32,000 workers (Marsh et al., 2001a (Marsh et al., , 2001b (Marsh et al., , 2001c Buchanich et al., 2001 ). The refined protocol included: redoing and updating work histories; including women for the first time; obtaining information on race; conducting a smoking survey of a sample of the entire cohort; initiating a new companion investigation to characterize, in addition to fiber exposures, other possible workplace confounding exposures (e.g., silica and asbestos); a nested, matched case-control study of respiratory system cancer deaths in males; and an investigation of mesothelioma in the cohort. The epidemiological studies are notable in that they ultimately included nearly a million person years of exposure extending from 1945 to the early 1990s. Thus, observations were made over a sufficiently long time period that excess cancer would be detected even if it had a long latency period. Marsh et al. (2001a Marsh et al. ( , 2001b Marsh et al. ( , 2001c , Buchanich et al. (2001) and Stone et al. (2001) described the results of the 1986 through 1992 update on the Enterline and Marsh (1981) cohort. This study involved a new historical exposure reconstruction for glass fibers, arsenic, asbestos, asphalt, epoxy, formaldehyde, polycyclic aromatic hydrocarbons, phenolics, silica, styrene and urea. It also included a nested case-control study of 631 respiratory cases, including those with smoking histories. The only outcome with a statistically significant excess risk in the updated analysis was respiratory cancer. However, the duration of fiber and other exposures, the cumulative exposures and the time since first exposure were not associated with cancer risk. Moreover, the smoking habit data indicated that smoking in the exposure cohort was greater than in the referent population suggesting that at least some of the respiratory cancer excess were likely due to smoking. One mesothelioma case was observed in the exposed cohort, while the expected number based on the referent group was 2.19. Stone et al. (2004) reported on the risk of respiratory system cancer among female workers in glass wool plants, RR = 1.02 (95% Confidence Interval, 0.76-1.34), based on four cases in exposed workers. Marsh et al. (2009) is the most recent summary of the epidemiological studies of exposed workers.
Setting the stage for new inhalation studies
By the early 1980s, it was also becoming increasingly accepted that inhalation exposure studies with well-characterized aerosols were the most appropriate approach to evaluating human health hazards for airborne materials in the absence of convincing epidemiological findings. During this time period, the Lovelace Inhalation Toxicology Research Institute, which continues today as part of the Lovelace Respiratory Research Institute in Albuquerque, NM sponsored a number of workshops to exchange information between established scientists in the field and acquaint new investigators with contemporary concepts in inhalation toxicology (McClellan and Henderson, 1989; McClellan, 1995) . The Lovelace inhalation toxicology research program, which was initiated in the 1960s to study radioactive aerosols, had expanded to consider other air contaminants such as specific chemicals and vehicle emissions and fibers. McClellan (2000a,b) has noted that much of the momentum for utilizing well-characterized aerosols in research came from the early experience with radioactive aerosols.
The importance of conducting studies using inhalation exposures, as contrasted with non-physiological modes of administering fibers, was emphasized in the conclusions of multiple workshops (McClellan et al., 1992; McClellan and Hesterberg, 1994; Vu et al., 1996) . McClellan (1995) in reviewing the role of experimental studies in informing human health risk assessments emphasized the importance of exposing laboratory rodents via inhalation to airborne respirable fibers that are comparable in size to those found in the workplace air. Researchers in the field, such as Hesterberg and Hart (1994) also began to reference data on workplace exposure (Table 3) which aids in placing the concentrations used in the animal exposure in perspective.
The conduct of large scale inhalation studies with rodents is expensive and time consuming. One very substantial initial cost, unique to studies with fibers, relates to the cost of the preparation of large quantities of size-selected fibers that are rat-respirable (<$1 lm diameter) required to conduct such studies. Thus, a decision was made for a new series of studies to conduct nose-only inhalation exposures which require less source material than required for conducting whole-body exposures (Bernstein et al., 1995) . In addition, the use of nose-only exposures minimizes the loss of fibers on the pelt of the animals and, thus, minimizes intake via ingestion as a result of grooming. As an aside, it is important to recognize that in both laboratory animals and humans some portion of inhaled fibers deposited in the upper airways are cleared to the oropharynx and ingested. A chronic exposure study involving exposures 5 days/week for 2 years will involve 500 exposure days. These studies typically require at least 3 years to conduct from initiation of detailed planning to completion of the histopathological interpretations and reporting. While inhalation studies are much more expensive and time-consuming than implantation/injection studies, they are clearly much more relevant for assessing the potential health hazards of fibers.
To assist in ensuring the quality of the research, a Science Advisory Group (SAG) was convened by J-M to help design the SVF research program, to provide oversight of the research and to aid in interpretation of the results. Members of the group were respected independent experts in the fields of medicine, veterinary medicine, public health, toxicology, epidemiology, aerosol science, industrial hygiene, and statistics. One of the authors (Roger O. McClellan) served as a member of the SAG. The results of the studies, as they became available, were shared with the scientific community, regulators, and the public. The results of the studies were also presented at scientific meetings and published in peer-reviewed scientific journals.
Each of the serious limitations in the pre-1987 studies was addressed in the new inhalation exposure study protocols. The limitations of the earlier studies included: use of test fibers with diameters too large to be readily inspired into the deep lung and/ or were too short to have unique carcinogenic properties; inadequate characterization of fiber numbers and dimensions in exposure aerosols and/or inadequate reportings; lack of measurement of the burden of fibers in the lungs, and the absence of a determination of whether the Maximum Tolerated Dose (MTD) had been attained. The MTD is highest daily dose that does not cause overt toxicity in a ninety-day laboratory study and is typically used in chronic exposure studies to maximize the likelihood of detecting any toxic effect including cancer (McConnell, 1996) .
To evaluate the potential for the material to cause health effects of any kind, specifically tumor induction, it is desirable in designing chronic inhalation exposure studies to include on multiple exposure levels with the highest exposure concentration selected to maximize the potential for detecting an excess of effects over that observed in controls. At the same time, it is desirable to avoid having an exposure level that is so high that non-specific toxic effects are produced that may interfere with the detection of test agent specific effects. Selection of the appropriate highest exposure level is always challenging (Lewis et al., 1989; McClellan et al., 1992; Hesterberg et al., 1999) .
The issue of conducting studies with aerosol exposures that might exceed the MTD came to the forefront in the 1980s with the observation of a high incidence of lung tumors in rats exposed to materials that were not genotoxic or were suspected of having low genotoxic potency. Of special note were findings from multiple studies conducted with whole diesel exhaust in which an excess of lung tumors was observed in rats, but not in mice, exposed to the same test atmosphere (Mauderly et al., , 1996 Hesterberg et al., 2005; Mauderly and Garshick, 2009) . Detailed studies on the deposition and retention of the diesel soot (carbonaceous particles and associated hydrocarbons) demonstrated that the retention of the inhaled particles was altered when the rats were exposed to high concentrations of particles (up to 7 mg/m 3 , 7 h/ day, 5 days/week) for extended periods of time (Wolff et al., 1987) . The resulting ''lung over-load'' led to a cascade of events including inflammation, cell proliferation, mutations, and ultimately, lung cancer. It is noteworthy that similar findings were observed with carbon black, which is free of any direct acting mutagenic chemicals, indicating that the effect observed with diesel exhaust particulates was not the result of direct acting mutagens associated with the particles (Nikula et al., 1995) . Driscoll et al. (1996) provided data on mutation induction related to particle burdens of Carbon Black that provided a basis for mechanistic interpretation of the findings of Nikula and colleagues. It soon became apparent that the development of lung tumors in rats associated with large lung burdens was a non-specific effect observed with many kinds of inhaled particles (Warheit et al., 1997) . The National Toxicology Program, recognizing that the issue of ''lung overload'' was of broad concern, convened a special Panel to offer advice on setting aerosol exposure concentrations for inhalation toxicity studies so as to avoid the non-specific pulmonary effects (Lewis et al., 1989 ). An awareness of the experience with ''lung overload'' and ''maximum tolerated dose'' (more correctly, maximum tolerated exposure) with non-fibrous aerosols stimulated special concern for these issues in planning the new generation of fiber inhalation studies (Hesterberg et al., 1996b) . The planning and conduct of the new fiber studies included the following advances:
(a) Use of size-separated fibers. It is now well known that fiber length and diameter are critical determinants of the toxicity of durable fibers-longer fibers (greater than 15 lm) were more toxic, while thinner fibers (less than 2 lm in diameter)
were more respirable. Indeed, particles (including fibers as a special form of particle) with an aerodynamic size of 3 micron or greater have a very low probability of being inhaled and reaching the alveolar region (Schlesinger, 1995; McClellan, 2000a,b) . Some earlier chronic inhalation studies were conducted using relatively short test fibers and/or fibers that were too thick to have a substantial portion of the fibers inhaled and deposited in the lungs. Thicker fibers deposit predominantly in the upper respiratory tract with, at best, only a small portion reaching what is viewed as the more vulnerable deep lung. Typically, the vast majority of fibers in glass wool insulation are too thick and long to be readily respirable. Techniques were developed to break the glass fibers and then selectively separate out the longer thinner fibers. Thus, the fibers prepared for use in the inhalation studies represented only a portion of the total mass, a portion thought to have the highest potential for producing effects. Thus, it was anticipated that the inhalation studies would represent a ''worse'' case situation relative to exposures in manufacturing facilities or by a user. Fibers observed in sampling workplace air were found to typically have an average diameter of 1 lm and an average length of 20 lm. Thus, techniques were developed to select fibers with these dimensions and prepare large quantities for use in animal exposure studies. The size selection techniques were innovative and used to prepare reproducible and consistent fiber sizes for a number of different fiber glasses and other synthetic vitreous fiber compositions. Thus, it was possible to compare the pulmonary effects of the various different fiber compositions in rats exposed by inhalation while minimizing the confounding variables of fiber length and diameter (Hesterberg et al., 1993) . (b) The average fiber diameter observed in the work place was similar to the diameter of fibers which would be respirable in the rat. Thus, techniques were developed to select fibers with similar dimensions and prepare large quantities for use in animal exposure studies. The size selection techniques were highly innovative and produced consistent fiber sizes for a number of different fiber glasses and other synthetic vitreous fiber compositions. Thus, it was possible to compare the lung effects of the various different fiber compositions in rats exposed by inhalation while minimizing the confounding variables of fiber length and diameter (Hesterberg et al., 1993) . The likelihood of inhaled fibers transiting the branched and narrow conducting airways of the respiratory tract and reaching the deep lung is determined by the inertial properties of the fibers. The inertial property of particles of different shapes and densities is characterized by their ''aerodynamic diameter,'' a comparison of their inertial properties to that of a spherical particle having a density of 1 g/cm 3
. Thus, it is important to characterize the aerosol of fibers as to their aerodynamic diameter along with fiber number and physical dimensions. The aerodynamic diameter is an important parameter to evaluate since the likelihood of a fiber being inhaled and deposited in the respiratory tract is primarily determined by its aerodynamic diameter. In planning and interpreting the studies with rats, it was recognized that this species is an obligate nose breather as contrasted with humans who breathe through both their nose and mouth. (c) The development of aerosol generation systems which do not break or grind the fibers. Most early inhalation toxicology studies with fibers had used the Timbrell aerosol generator or similar devices for the aerosolization of fibers, recall the LANL studies reported by Smith et al., 1987 . This device required the fibers to be compressed into a plug, a rotating steel blade scraped fibers off the plug into the air stream. This process reduced the length of some fibers and, in addition, added metal contaminants from the scraping surface into the fiber air stream. To avoid these problems and to be able to aerosolize the bulk fibers without altering their characteristics or dimensions, a new aerosol generation device was developed using a rotating brush feed system (Bernstein et al., 1994 (Bernstein et al., , 1995 .
(d) Quantitative reporting of fiber numbers and dimensions in aerosols. The methods used allowed the aerosols to be characterized in units of fibers/cc of air as well as more typical measures of particle mass reported in units of mg/m 3 . In addition, the bivariate diameter and length of fibers in both the aerosol and in the lung was routinely characterized in the studies. (e) Lung burdens. Techniques were developed to characterize the lung burden of fibers as to their number and fiber dimension. This allowed results to be analyzed not only with regard to exposure concentration as was traditional, but with regard to lung burden. This facilitated the evaluation of the deposition and clearance of the inhaled fibers and, ultimately, a comparison of various kinds of fibers based on their biopersistence 5.3. Industry-sponsored chronic inhalation studies (post-1987) The studies sponsored by the Thermal Insulation Manufacturer's Association, and later, the North American Insulation Manufacturers Association were conducted by the Research and Consulting Company (RCC), a Swiss firm, over a period of ten years. The studies were initially conducted in the facilities and with equipment and procedures developed by Battelle-Geneva under the direction of one of the authors of this paper (DMB). Later, the operations were moved to RCC facilities at Itengen, Switzerland. The studies conducted under contract by RCC were at the core of the fiber glass industry's product stewardship program. The cost of the studies exceeded over $30 million (in 1990 dollars).
At the time these studies were planned, it was well recognized that certain types of asbestos were carcinogenic in humans based on epidemiological evidence (IARC, 1987) . Animal studies with asbestos were clearly not needed to bolster this conclusion. However, it was recognized that well-conducted inhalation studies with asbestos fibers known to be carcinogenic to humans were required to validate the experimental animal protocol being used to evaluate the carcinogenic potential of the synthetic fibers. Thus, the core program included ''positive control'' groups exposed to Amosite or Crocidolite asbestos, anticipating that these fibers known to be human carcinogens based on epidemiological evidence would produce an excess of tumors in laboratory animals.
A total of nine different synthetic fiber types were studied (Table 4) (Bernstein et al., 1996 (Bernstein et al., , 1997 Davis et al., 1996; Hesterberg et al., 1993 Hesterberg et al., , 1997 Hesterberg et al., , 1998a Hesterberg et al., , 1998b Hesterberg et al., , 1999 Hesterberg and Hart, 2001; Kamstrup et al., 1996; Mast et al., 1995a Mast et al., , 1995b McConnell et al., 1994 McConnell et al., , 1999 . The United States Environmental Protection Agency (US EPA) and the Occupational Safety and Health Administration (OSHA) were invited to comment on the study protocols before the studies were initiated to encourage the use of the results for regulatory purposes, irrespective of whether an excess of tumors were or were not observed. These agencies were also provided with the interim study results as they became available and, of course, the agencies received the final reports and published papers.
The basic protocol for the chronic studies, to evaluate carcinogenic potential, involved nose-only exposure (6 h/day, 5 days/ week) of rats and Syrian hamsters for up to two years with animals monitored for the rest of their lives (Bernstein et al., 1995) . Rats were selected for use as the rat had been shown to be the most robust laboratory animal for inhalation studies with airborne particulate materials. Syrian hamsters were also used primarily because they had been used in the earlier industry studies conducted at the Los Alamos National Laboratory in the 1980s. Moreover, during that time period Syrian hamsters were being used increasingly in inhalation studies with airborne particulate materials. Mice were not considered appropriate for use in these studies recognizing that the relatively small size of the airways in mice limits the upper bound of the size of particles that mice can inspire (Snipes, 1989) .
The fiber aerosols were produced using a special aerosol generation system developed at Battelle-Geneva and RCC (Hesterberg et al., 1993; Bernstein et al., 1994 Bernstein et al., , 1995 . The animals were exposed nose-only in a special exposure system that had originally been developed at the Pacific Northwest Laboratories (Cannon et al., 1983) , the system provided for continuous laminar flow of the contaminated air past the nose of each animal restrained within its own exposure tube and with exhaled air diverted so it did not reach other animals being exposed concurrently. The fiber concentrations were monitored continuously with a light-scattering instrument. Direct fiber mass measurements were made on samples collected with membrane filters. In addition, samples were collected periodically for electron microscopic determination of fiber dimensions. The target aerosol concentrations for the fiber glass exposure groups were 3, 16 and 30 mg/m 3 with concurrent controls exposed to clean air. A number of health indicators were routinely evaluated. Special care was taken to conduct detailed gross and histopathological evaluations of the respiratory tract. From Table 4 , it is apparent that the amosite and crocidolite exposed groups developed an excess of respiratory tract tumors as expected. In addition, it is apparent that an excess of respiratory tract tumors were observed in the Groups exposed to MMVF32, (a special purpose glass fiber) and the RCF1a, (a refractory ceramic fiber). One mesothelioma (in 83 Syrian hamsters) was observed in the MMVF33 (a special purpose glass fiber) Group. Five Groups (MMVF10, X607, MMVF11, MMVF22, and MMVF34) did not have an excess of respiratory tract tumors. These Groups had all been exposed to more soluble fibers that were substantially less biopersistent than the amosite and crocidolite fiber and the special purpose fibers.
Sub-groups of animals were periodically killed and their lungs taken for determination of the fiber burden (Hesterberg et al., 1996b) . The lungs were dried and plasma ashed to provide specimens for quantification of the lung burdens of fibers and determination of fiber dimensions.
From the results of chronic exposure studies, it soon became clear that ''biopersistence'' was the key determinant of the toxicity of a synthetic vitreous fiber (Bernstein et al., 1994; Hesterberg et al., 1996b) . Biopersistence refers to the ability of fibers to persist in the lung over time. In the chronic studies, the five types of synthetic vitreous insulation fibers that had low biopersistence, did not cause lung fibrosis or tumors even when laboratory animals were exposed to high concentrations of long, respirable fibers. One synthetic rock wool fiber type produced fibrosis, however, it did not produce tumors. The statistically significant positive tumor findings in the two asbestos groups (amosite and crocidolite) and two of the synthetic fiber groups (Special Purpose E Glass and Refractory Ceramic Fiber) validated the bioassay as being capable of detecting tumorgenic activity. The observation that the two synthetic fibers that were biopersistent produced an excess of lung tumors motivated the fiber industry to initiate additional experiments to gain a better understanding of the importance of the biopersistence in determining the lung disease causing potential of SVFs.
Short-term animal biopersistence studies
In the chronic inhalation studies, fiber biopersistence, which is influenced by chemical composition and manufacturing mode, emerged as an important determinant of fiber pathogenicity. Fiber dissolution is a measure of how quickly a fiber dissolves in a simulated body fluid in a test tube (in vitro). It was hypothesized that fiber dissolution rates could serve as a surrogate for the more relevant parameter, biopersistence in the lung (Bernstein et al., 1994; Hesterberg et al., 1998a,b; Hesterberg and Hart, 2000) . In vivo biopersistence studies measures how long fibers persist in the lungs after being deposited. Some fibers crumble (break transversely) and/or dissolve relatively quickly in the lung environment, while other fiber types persist for longer periods of time or even appear to be indefinitely retained (see Fig. 2 ).
In order to understand the actual fate of inhaled fibers in the lung, protocols were developed for measuring biopersistence of fibers in the rat lung (Bernstein et al., 1994; Hesterberg et al., 1996a; Hesterberg and Hart, 2001 ). These studies were designed to evaluate the number and dimensions of fibers retained in the lung over time. In the biopersistence studies, rats were exposed by nose-only inhalation techniques for five days, 6 h per day to aliquots of the same fibers used in the chronic studies (nine different SVFs and Kamstrup et al. (1998) ; others from Eastes and Hadley (1996) . K dis values may differ from those published elsewhere due to varying methodologies. e k leach dissolution rate constant of leaching elements represented by Ca and Mg at pH 4.5 (rounded up to whole numbers). Source: Guldberg et al. (1998) . f nd, not done. g RCF1 was used in pathogenicity studies. RCF1a was modified from RCF1 to contain fewer non-fibrous particles. h ± indicates tumorigenicity in hamsters (one mesothelioma in 83 animals) but not in rats. i Clearance half-time of 14.5 days was determined using a modified MMVF10 test fiber that had been size-selected to have longer and thinner average dimensions than the original MMVF10. two asbestos types) and then held without further exposure. The exposure of animals for 30 h to an aerosol of the test fiber assured that the lung burden of fibers would be sufficiently large that the decrease in lung burden could be followed for some time.
At several time points up to one year after exposure, the lung burdens of fibers were evaluated. The results of lung burden biopersistence for crocidolite and MMVF-11 (Insulation Glass Wool) groups exposed for five days is shown in Fig. 2 . The long-term biopersistence of the crocidolite fibers is very apparent. In particular, note the substantial fraction of the crocidolite fibers (over 5 lm, over 10 lm and over 20 lm in length) that were retained for up to a year after cessation of exposure. Over one-half of the crocidolite fibers over 20 lm in length were present at one year after initiation of the exposures. In contrast, with the MMVF-11, fibers, an insulation glass wool, only a small fraction of the material was present in the lungs one year after 5 days of exposure. There were essentially no glass fibers longer than 10 lm in length retained after six months.
Different fiber types were compared based on how long it took to clear half of the original fibers from the lung. A metric, the weighted lung clearance half-time (WT 1/2 ), which took into account both the trachea-bronchial clearance and the deep-lung clearance of fibers, was developed to compare the clearance rates of different fiber types from the lung. Based on this work, it was found that the single parameter, WT 1/2 , correlated very well with the chronic toxicity produced by the fibers (Table 4) .
As presented above, the relationship between biopersistence and chronic toxicity was considered sufficiently strong (Bernstein et al., 2001a (Bernstein et al., , 2001b ) that the European Commission incorporated both biopersistence and chronic toxicity evaluations as criteria for the exoneration of the fibers as a carcinogen (Commission Directive 97/69/EC of 5 December 1997) as will be discussed later. In order to facilitate the limitation of these tests for the Commission Directive, detailed protocols were established by the European commission (Bernstein and Riego-Sintes, 1999) . In addition, a protocol was developed and included in this set for this sub chronic inhalation toxicity (90 days) evaluation for fibers. These protocols have become the de facto standard for evaluating either the biopersistence or the chronic toxicity of fibers and the potential for the synthetic fibers to cause cancer.
These biopersistence studies were critical to understanding why some fibers produce pathogenic changes and others do not. A major goal of the research effort was to determine if the results of short-term biopersistance tests were a valid predictor of longterm toxicity and carcinogenicity. It was anticipated that if the short-term test could be validated as a predictor of long-term toxicity, it would certainly justify the substantial expense of conducting the validation studies. Without question, biopersistence studies cost less money, require fewer animals, and can be completed within a few months, compared to lifetime chronic carcinogenicity studies, which costs millions of dollars, utilize hundreds of animals, and take several years to complete (Hesterberg and Hart, 2001) . The need to use fewer laboratory animals is a benefit relative to Animal Welfare considerations. Moreover, the quick turnaround time associated with short-term tests was viewed as advantageous for the development of new fibers for introduction into the marketplace.
In vitro fiber dissolution studies
In vitro fiber dissolution was another field in which major contributions were made by researchers at J-M and in other fiber industry laboratories. In these studies, J-M researchers developed methods to study the dissolution and breakdown of fibers in vitro in simulated biological fluids in the absence of cells. The fluids simulated both lung extracellular fluid and the more acidic intracellular lysosomal environment of alveolar macrophages, which assist in clearing the lower lung of inhaled debris (Bauer et al., 1994) . The results of these in vitro studies showed reasonably good correlation with the results of the rodent inhalation biopersistence studies (Table 4 ). The in vitro fiber dissolution studies contributed very significantly to a better understanding of fiber biopersistence and degradation in the lung. However, the results did not correlate as well to the results of the rodent chronic inhalation carcinogenicity studies as did the results of the in vivo biopersistence studies. Chronic exposure to SVFs or any of the fibers with low biopersistence produced neither tumors nor fibrosis in animal inhalation studies. After the importance of biosolubility was determined, J-M evaluated each of its fiber formulations to determine whether a more soluble fiber composition could be developed while still meeting the performance requirements of the particular product.
The short-term biopersistence tests, both in vitro and in vivo, (Bernstein and Riego-Sintes, 1999; Hesterberg et al., 2002) proved valuable in guiding the development of new fiber formulations. For example, at J-M two new glass fibers were developed for optimal biosolubility in the lung; J-M 902 for insulation and filtration use; 481 for filtration use, and J-M 901F for thermal and acoustical insulation use. All three types of fibers were evaluated for lung biopersistence and short-term toxicology in rats and for in vitro dissolution rates. Both types of fibers passed the criteria established by The Commission of the European Communities (EU, 1997) that will be discussed later and, thus, do not need to be identified as potential carcinogens when sold in the EU market.
Cell studies (post-1987)
In 1989, J-M began conducting in vitro studies with fibers as part of its expanded research program. Over the next 8 years, J-M conducted a series of studies in which various types of cultured cells were exposed in vitro to the same size-selected manmade and asbestos fibers that were being tested in the rat and hamster inhalation studies, as well as to numerous other fiber sizes and compositions Hesterberg and Hart, 2001) . In these studies, for all the fiber compositions tested, cytoxicity (cell death or failure to proliferate) and genotoxicity (disruption of the nuclear material, i.e., the genetic material) were directly proportional to fiber number per cell and fiber length. The results of these studies showed that longer fibers were more toxic than shorter fibers, no matter what the composition was of the fibers studied . This consistent finding of cellular effects was in striking contrast to the results of the chronic rodent inhalation studies with SVFs. Recall that six of the nine different SVFs studied did not cause lung fibrosis and seven of the nine synthetic fibers did not produce an excess of respiratory tract tumors (Table 4) . Since some SVFs were not toxic, even at the MTD, in the chronic inhalation studies, but all fibers compositions were toxic in the cell culture studies, it was clear that the in vitro cell culture models generated false positive results as predictors of in vivo toxicity and carcinogenicity. Thus, it was reasonable to conclude that the results of the in vitro assays should not be considered valid for assessing human health hazards from SVFs (Hesterberg and Hart, 2001) . Some scientists have argued that information gained from in vitro studies with fibers, can provide useful insight into the mechanisms that cause toxicity and, indeed, tumors. However, the fact that a mechanistic step is observed in a high dose in vitro study does not automatically translate to that same mechanism occurring in in vivo studies conducted with laboratory animals at low exposure concentrations.
The biopersistence studies demonstrated that, in the whole animal, fiber dissolution, breakage, and lung clearance remove the non-biopersistent fiber constituents from the lung. This provided a rational explanation as to why some fiber compositions do not cause lung cancer or fibrosis, even at very high exposure concentrations. As with the intra-cavity implantation studies, in vitro cell culture models do not include the natural deposition and clearance mechanisms found in intact animals that have been exposed by inhalation to fibers.
Critique of intra-cavitary studies
It was not until the 1980s that the experimental approach using intra-cavity injections began to be critically evaluated. The nonphysiological exposure method differs markedly from the manner in which people might be exposed in the workplace, which is by inhalation of airborne fibers. The numerous problems associated with the non-physiological exposure methods, led many scientists to conclude later that the results were not appropriate for evaluating the human health risks of fibrous dusts (Eastes and Hadley, 1994; Collier, 1995; Collier et al., 1995; McClellan et al., 1992; McClellan and Hesterberg, 1994; McConnell, 1995; Rossiter, 1991) . These views were also reflected in reviews conducted by various national and international groups (US Office of Science and Technology Policy (OSTP) 1985, International Program on Chemical Safety (IPCS, 1988) : National Institute for Occupational Safety and Health (NIOSH, 1977 (NIOSH, , 1987 : the World Health Organization (WHO, 1992) : the National Research Council (NRC, 2000) of the National Academy of Science: and, the Agency for Toxic Substance and Disease Registry (ATSDR, 2004) . The major concerns they described were as follows:
(a) Implantation/injection of fibers bypasses the natural defense mechanisms that are operative with inhaled fibers. For example, the upper airways naturally filter out larger fibers and prevent them from entering the deep lung; lung cells and mucus efficiently remove many of the fibers that are inhaled and deposited in the airways and in the deep lung. (b) Very large fibers, which could not normally be inhaled into the lung, can easily be implanted or injected. Fibers with a large aerodynamic diameter are non-respirable, which means they have limited potential for becoming airborne and remaining suspended in the air and traveling with the inhaled air into the lower lung. Such non-respirable fibers are not relevant to the respiratory health of people. However, these fibers can and often were injected into the body cavities of laboratory animals. (c) IP or IT tests typically use very large quantities of fibers such that a substantial portion of the injected fibers tends to be concentrated at the injection site. With these large quantities, ''Normal physiology, homeostasis and detoxification or repair mechanisms may be overwhelmed and cancer, which otherwise might not have occurred, is induced or promoted'' (OSTP, 1985) . (d) Target cells for the fibers that are injected or implanted into the peritoneal abdominal cavity are not the same as for respiratory tissues that are exposed via inhalation of fibers.
Using the new scientific information

Equivocal findings
The results of the chronic inhalation studies with Syrian hamsters and rats exposed to high concentrations of MMVF33 fibers (Special Purpose 475 Glass), manufactured at that time by J-M, were reported by McConnell et al. (1999) . There were no respiratory tract tumors observed in the rats that inhaled MMVF33 fibers. However, a single mesothelioma was observed in one of the 83 Syrian hamsters that were exposed to these same fiber preparations. It could be argued that the finding of a single mesothelioma was not statistically significant. However, J-M elected to take a more cautious approach and initiate a thorough health risk assessment.
The MMVF 33 product was manufactured at only one plant. Company scientists reviewed the worker exposure levels, work practices and engineering controls and concluded that the existing 1 fiber/cc workplace exposure guideline, voluntarily implemented by J-M, together with a requirement to wear respirators would be adequately protective of the production workers. J-M also developed and installed engineering controls to further reduce exposure levels in the workplace. As an aside, modern fiber glass production facilities are remarkably different than the production facilities used in the early days of the industry. Increased attention has been given to ventilation and to the isolation of phases of the production process that have the highest probability for release of respirable fibers. Increased automation minimizes the need for production workers to enter areas with high concentrations of respirable fibers. Not surprisingly, the greatest potential for worker exposure occurs during maintenance of the production equipment. These exposures can be avoided by maintenance workers using respirators. In addition to the epidemiology programs, medical monitoring of the workers was increased. This included periodic pulmonary function testing, lung radiographs and health questionnaires. These data were evaluated on an ongoing basis to complement the epidemiological studies. Exposure monitoring was also conducted at customer workplaces to ensure that the recommended 1 fiber/cc guideline was consistently met.
Voluntary exposure guidelines
It is worth noting that in the early 1990s, J-M established a voluntary workplace exposure guideline of 1 fiber/cc for its operations. A cynical view of such action might be that the company was seeking to avoid legal liability in light of its adverse asbestos experience. However, a more balanced view is that it was consistent with J-M's proactive product stewardship approach. This is the case since OSHA did not establish the separate personnel exposure limits (PEL) for fiber glass, but rather allowed fiber glass to be regulated within the PEL set for nuisance dust (15 mg/m 3 total dust and 5 mg/m 3 respirable dust). Since an atmosphere containing 30 mg/m 3 fiber glass may contain 280 total fibers/cc (Hesterberg et al., 1993) , the OSHA PEL of 5 mg/m 3 would roughly equate to 47 fibers/cc. This would be substantially higher than J-M's voluntary workplace guideline.
ACGIH guidance
In 1997, the American Conference of Governmental Industrial Hygienists (ACGIH), classified fiber glass and mineral wools as A3, Animal Carcinogen (ACGIH, 1997). The ACGIH found that the ''fibers appear to be carcinogenic only by unusual routes of exposure to test animals (e.g., intrapleural and intraperitoneal injection and possibly intratracheal injection) that are not considered relevant to worker exposure. Animal inhalation studies of these fibers have not produced significant tumors. Available epidemiologic studies do not confirm or support an increased risk of cancer in exposed humans. The evidence suggests that the agent is not likely to cause cancer in humans except under unlikely routes of exposure, carcinogenic in experimental animals at dose levels, by route(s) of administration, which are not considered relevant to worker exposure.'' The ACGIH recommended an exposure limit (threshold limit value time weighted average, TLV-TWA) of 1 respirable fiber/cc for fiber glass and mineral wool. This recommendation was consistent with the guideline concentration value J-M had established earlier.
Health and safety partnership agreement with occupational and health administration
In 1999, Occupational Safety and Health Administration (OSHA) , trade associations representing US insulation manufacturers, and insulation contractors agreed to a voluntary standard for exposure to glass fibers. The initial position of the OSHA representatives was that the permissible exposure limit (PEL) should be should be set at 0.1 fiber/cc (the same as the revised asbestos standard). However, after discussions and a review of the relevant research, the participants agreed to a voluntary Health and Safety Partnership Program (HSPP) that included a Voluntary PEL of 1 respirable fiber/cc and a commitment from manufacturers to formulate or reformulate fibers with an increased biosolubility as necessary (NAIMA, 1999) . The manufacturers also committed to monitor occupational exposure to fiber glass and as a result built a database of over 14,000 data points reflecting fiber concentrations in various fiber glass-related job tasks. Charles Jeffress, who was then Head of OSHA, wrote ''The Health and Safety Partnership Program provides benefits to workers that even the most tightly worded regulation may not ensure'' (OSHA, 1999) . 
Carcinogen classification based on new scientific information
International agency for cancer research re-evaluation (2001-2002)
In 2001, IARC convened a Panel to reevaluate the carcinogenic risk of Synthetic Vitreous Fibers, the Working Group's findings were published the following year (IARC, 2002b) . Importantly, the IARC Panel determined that the human epidemiology data for glass wool, continuous glass filaments, rock (stone) wool, slag wool and ceramic fibers were inadequate, i.e., the studies did not provide evidence of a carcinogenic response. For purposes of hazard determination, this time the IARC panel decided that the scientific evidence was sufficient to differentiate the man-made fibers into six separate SVF categories ( Table 2 ). The IARC decision to divide man-made fibers into multiple categories was heavily influenced by the large number of well-conducted animal chronic inhalation carcinogenicity and biopersistence studies that had been sponsored by J-M and the rest of the industry between 1987 and 2001 (summarized in Table 4 ). These studies showed that the biopersistent refractory ceramic and special purpose fibers tested were carcinogenic in animals by inhalation exposure. In contrast, the less biopersistent insulation glass wool fibers were not carcinogenic. These results were readily explained by differences in the biopersistence in the lung of these two fiber types. The classification of the several types of fibers as to carcinogenicity would depend on the results of the animal studies since there was no epidemiological evidence for any of the fiber types having a carcinogenic response, including the durable special purpose fibers.
The 2002 IARC Monograph also made other important changes in the classification of glass wool compared to the 1988 Monograph. These changes resulted primarily because the evidence for insulation glass wool fibers producing tumors using the intraperitoneal (IP) test and other intracavity administration methods noted earlier by IARC (1988) could now be interpreted by considering the absence of an excess of tumor findings in well-conducted chronic inhalation bioassays that had been validated for their ability to detect tumor responses elicited by fibers. This resulted in the IARC Panel concluding there was only ''limited'' evidence for carcinogenicity of insulation glass wool, rock (stone) wool and slag wool fibers in animals. On the other hand, the new finding that an excess of respiratory tract tumors was found in laboratory animals exposed to refractory ceramic and special purpose fibers in well-conducted animal inhalation studies, coupled with the old finding of tumors in IP tests could now be viewed as ''sufficient'' animal evidence for the carcinogenicity of refractory ceramic and special purpose fibers. The 2002 IARC Monograph concluded that insulation glass wool continuous glass filaments, rock (stone) wool, and slag wool fibers were ''not classifiable as to their carcinogenicity to humans (Group 3)'' (IARC, 2002b) . The traditional special purpose fibers and RCF were retained in Group 2B.
It is noteworthy that the IARC Working Group ''elected to not make an overall evaluation of the newly developed fibers designed to be less biopersistent such as the alkaline earth silicate or high alumina, low-silica wools. This decision was made in part because no human data were available, although such fibers that have been tested appear to have low carcinogenic potential in experimental animals, and because the Working Group had difficulty categorizing these fibers into meaningful groups based on chemical composition.'' The comment on ''no human data'' indicates a dilemma associated with evaluating the carcinogenic hazard of any newly developed material, there will be no human data because the material has just entered commerce. Thus, it becomes important to use the results of short-term tests such as the biopersistence tests described earlier and traditional two-year bioassays, as predictors of the likelihood or lack of likelihood that a newly developed material has carcinogenic properties. This situation will be discussed in greater detail later.
The designation of the four fiber types as Group 3 -, ''not classifiable as to carcinogenicity to human,'' deserves further comment. Presumably, these fibers could have been considered for placement in Group 4 -''probably not carcinogenic to humans.'' It is noteworthy that since the beginning of the Monograph Program, IARC panels have placed only a single compound, Caprolactam, a chemical used in producing nylon, in this group (IARC, 1979) . This use of the Group 4 classification occurred in the early days of the IARC Monograph Program. This can be interpreted as illustrating the reluctance of IARC Panels to use the Group 4 classification even in the face of negative data as to carcinogenicity of a particular substance.
European Commission's Directive on synthetic mineral fibers
The European Commission regulates hazardous chemicals under the Directive for Classification and Labeling of Dangerous Substances (Council Directive 67/548/EEC). Directive 97/69/EC, specifically addressing synthetic fibers, was enacted on the 5 December 1997 which adopted 'for technical progress' the Dangerous Substances Directive (EU, 1997; Bernstein, 2007) .
Following IARCs initial classification in 1988 and the review of synthetic mineral fibers by the WHO International Program on Chemical Safety in 1988, the European commission initiated steps for the classification of synthetic mineral fibers. Working with industry initial proposals for classification schemes were submitted to the Commission in 1989. Discussion of alternative classification schemes continued in the early 1990s, however, no agreement on a classification scheme.
In 1996, a meeting was convened by the EC to discuss the scientific basis that could be used for establishing a synthetic mineral fiber directive. At that meeting the chronic inhalation and intraperitoneal injection studies and their relationship with the fiber biopersistence studies presented in this paper were discussed. This led to a mandate by the EC to convene an Expert Working Group to provide a systematic evaluation of the relationship of biopersistence to the chronic study results. As part of this mandate a 'call for data' was issued requesting as much as possible the original data files for the various studies. These data were used to independently evaluate the results from the different types of studies.
The expert group found that: The inhalation and intratracheal instillation biopersistence T1/2
(half-life in the lung) of Fibers L > 20 lm was found to correlate with: (a) number of fibers L > 20 lm remaining after 24 months exposure in the chronic inhalation studies; (b) early pulmonary fibrosis in the chronic inhalation studies, and (c) number of tumors in the IP studies when fiber length and number fibers injected are taken into account. These results became the basis for the synthetic mineral fiber Commission Directive 97/69/EC of 5 December 1997 (Adopting for technical progress for the 23rd time Council Directive 67/548/ EEC, classification and labeling of dangerous substances). The scientific results that served as the basis of the Directive were subsequently published (Bernstein et al., 2001a (Bernstein et al., , 2001b .
The European Commission (EU, 1997), adopted a formal directive for not classifying certain fibers as a carcinogen if they met certain criteria or, as some have called it, an exoneration process. Specifically, ''The classification as a carcinogen need not apply if it can be shown the substance fulfills one of the following conditions:
-a short-term biopersistence test by inhalation has shown the fibers longer than 20 lm have a weighted half life less than 10 days, or -a short-term biopersistence test by intratracheal instillation has shown that the fibers longer than 20 lm have a weighted halftime less than 40 days, or -an appropriate intra-peritoneal test has shown no evidence of excess carcinogenicity, or -absence of relevant pathogenicity or neoplastic change in a suitable long-term inhalation test.''
The adoption of this formal directive served as a major stimulus to European Synthetic Fiber Manufacturers developing, testing and, then, marketing synthetic glass fibers that had low biopersistence and could meet the criterion for exoneration from identification as a carcinogen in the absence of data from chronic bioassays. The development of a regulatory paradigm that avoided the need for conducting long-term studies utilizing large numbers of animals was also consistent with a growing movement around the world to minimize the number of laboratory animals used in research. No doubt, the European Commission (EU, 1997) Directive also influenced the manufacture and marketing of low biopersistence, and hence, safer fibers, in other markets around the world.
National Toxicology Program 12th report on carcinogens
In view of the substantial body of new science and the action of IARC (2002b) on that science, the North American Insulation Manufacturers Association in 2002 (Hadley and Mentzer, 2004) requested that the National Toxicology Program, as it began preparing the 12th RoC, re-evaluate its listing of ''Glass Wool (Respirable Size) as ''reasonably anticipated to be a human carcinogen.'' This listing was first published in the 7th Report on Carcinogens (NTP, 1994) and remained unchanged in each report through the 11th Report on Carcinogens (NTP, 2004) . Unifax (Carey, 2004) , a manufacturer of refractory ceramic fibers endorsed the need for re-evaluation of the listings for vitreous synthetic fibers.
The preparation of the 12th Report on Carcinogens extended over a number of years and was finally concluded when the report was released on June 10, 2011 (NTP, 2011a,b) . It is beyond the scope of this paper to review all of the details of the NTP reevaluation process for glass wool fibers, however, key aspects of the process will be briefly described. Detailed information, including various reports cited later, can be found on the NTP website.
In accord with the announced NTP process (NTP, 2009a), a draft background document was prepared and released for public comment -''DRAFT, Report on Carcinogens Background Document for Glass Wool Fiber' ' (NTP, 2009b) . The draft document was prepared by SRA International, Inc. under an NIEHS Contract. Subsequent to release of the draft document, Hadley (2010a) provided complete documentation for a study of glass fibers conducted many years earlier for the National Institute for Occupational Safety and Health at Battelle Memorial Institute, Columbus (Mitchell et al., 1982) . This study had been reported in summary form in the open literature by Mitchell et al. (1986) and Moorman et al. (1988) , reports cited in the draft substance profile.
A number of comments were submitted to the NTP critiquing the draft background document (Bauer, 2009; Crane, 2009a; Donaldson, 2009; Hadley, 2009; Hesterberg, 2009; Marsh et al., 2009; Mentzer, 2009; Ray and Bauer, 2009 ). These comments summarized more than two decades of research and hundreds of peer-reviewed publications, largely sponsored by the glass fiber industry.
The NTP's review process for preparation of the 12th RoC calls for the use of an Expert Panel to provide scientific advice on the listing (or de-listing) of each of the substances under consideration for listing in the Report (Fig. 1) . The NTP appointed to the Glass Wool Fibers Expert Panel nine highly qualified scientists with recognized expertise in aerosol science, inhalation toxicology, industrial hygiene, pulmonary medicine, pulmonary biology/ pathobiology and hazard evaluation. The NTP Expert Panel was charged (1) to apply the RoC listing criteria to the relevant scientific information and make recommendations regarding its listing status (i.e., known to be a human carcinogen, reasonably anticipated to be a human carcinogen or to not list) in the 12th RoC, and (2) to provide a scientific justification for the recommendation (NTP, 2009b) . The Expert Panel received the draft background document in advance of its meeting.
The Glass Wool Fibers Expert Panel, at its meeting on June 9-10, 2009, heard oral presentations from many of the individuals who had offered written comments to the NTP on the draft background document. Undoubtedly, the individual members of the NTP Expert Panel were also knowledgeable of the IARC (2002b) Monograph that provided scientific documentation for most recent IARC separate evaluation of man-made fibers.
The peer review findings and listing status recommendations of the Expert Panel were contained in two reports, Part A and B (Kelsey, 2009a,b) . The recommendations of the NTP Glass Wool Fibers Expert Panel with regard to the listing (de-listing) of glass fibers were clear and unambiguous.
The Expert Panel, by a vote of 8 Yes and 0 No, recommended ''that glass wool fibers, with the exception of special fibers of concern (characterized physically below), should not be classified either as known to be a human carcinogen or reasonably anticipated to be a human carcinogen.'' The NTP Expert Panel also recommended by a vote of 7 yes, 0 no and 1 abstention, ''based on sufficient evidence of carcinogenicity in well-conducted animal inhalation studies, that special purpose glass fibers with the physical characteristics as follows -longer, thinner, less soluble fibers (for example, P15 lm length with a K dis of 6100 ng/cm 2 /h) -reasonably anticipated to be human carcinogens for the listing status in the RoC.'' By offering two separate and distinct recommendations based on scientific evidence, the NTP Expert Panel was making a strong statement that it was scientifically inappropriate to continue the practice of lumping all glass fibers together within a single listing for human carcinogenicity as originally done in the 7th RoC and continued through the 11th RoC. The NTP Glass Wool Fibers Expert Panel clearly expressed a scientific opinion that the physical properties and related carcinogenic effects in laboratory animals for certain synthetic fibers warranted listing these fibers as ''reasonably anticipated to be human carcinogens.'' It is equally clear the NTP Glass Wool Fibers Expert Panel was of the opinion that scientific evidence did not support listing less biopersistent glass wool fibers as ''reasonably anticipated to be a human carcinogen.''
The recommendations of the Glass Wool Fibers Expert Panel were subsequently published in the Federal Register with a request for public comments (NTP, August 12, 2009) . At least three letters were submitted to the NTP supporting the recommendations of the NTP Expert Panel (Crane, 2009b; Ray and Baure, 2009; Venturin, 2009) .
Following receipt of the Expert Panel's Reports (Kelsey, 2009a,b) , the NTP presumably convened two separate Working Groups to meet in closed sessions to recommend listing status for the candidate substance as described in the RoC review process (NTP, 2009a) . The membership and the deliberations of these two Groups (the Interagency Scientific Review Group and the NIEHS/NTP Scientific Review Group) have not been made public. As an aside, the RoC review process in the future could be improved by having these Working Groups meet in public sessions so the total process will be more open and transparent. Although the details are not known, the ''DRAFT, Report on Carcinogens Background Document for Glass Wool Fibers'' (NTP, 2009b) was transformed into a second document -''DRAFT Report on Carcinogens Substances Profile for Glass Wool Fibers (Respirable) as a Class (NTP, 2011a,b) .
The Draft Substance Profile contained a single preliminary recommendation -''Glass Wool Fibers (Respirable) as a Class, CAS No. None Assigned, Presumably anticipated to be a human carcinogen, first listed in the Seventh Report on Carcinogens (1994) .'' This recommendation appeared to be at complete odds with the recommendations of the Glass Wool Fibers Expert Panel (Kelsey, 2009a,b) and public commentors.
The NTP Board of Scientific Counselors (BSC) discussed the ''Report on Carcinogens Substance Profile for Glass Wool Fibers (Respirable) as a Class'' at a meeting on June 21, 2010. The Board was provided oral and written comments by representatives of the fiber glass industry (Donaldson, 2010; McClellan and Hahn, 2010; Hesterberg, 2010; Crane, 2010a,b, and Hadley, 2010b; Ray, 2010) . The commentors succinctly reviewed the scientific evidence considered by IARC (2002b) which provided a separate evaluation and classification of the several types of man-made fibers. They also summarized the NTP Glass Wool Fibers Expert Panel recommendations (Kelsey, 2009a,b) and the science that informed that Panel's recommendations for listing as ''reasonably anticipated'' only special fibers of concern. Basically, the commentors endorsed the science-based recommendations of the NTP Glass Wool Fibers Expert Panel and urged the NTP to follow the scientifically sound advice of its Expert Panel and to proceed expeditiously with preparation of the 12th Report on Carcinogens. The members of the BSC offered comments which are recorded in the minutes of the meeting.
On June 10, 2011, the NTP formally released the 12th RoC (NTP, 2011a,b) . It contained the entry -''Certain Glass Wool Fibers (Inhalable), CAS No: none assigned, Reasonably anticipated to be a human carcinogen.''
The word ''Certain'' in ''Certain Glass Wool Fibers (Inhalable)'' is defined by the phrase in the opening paragraph of the supporting documentation -''only certain fibers within this class -specifically fibers that are biopersistent in the lung or tracheobronchial region -are reasonably anticipated to be human carcinogens.'' It is inferred from the language of the documentation and the NTP media release and questions and answers that the NTP views biopersistent glass fibers to be ''reasonably anticipated to be a human carcinogen'' and more soluble and, hence, less biopersistent glass fibers that have been assessed in animal studies to not be of equivalent concern with regard to carcinogenic hazard.
This position is consistent with the recommendations of the NTP Glass Wool Fiber Expert Panel on the importance that fiber biopersistence plays in hazard determination but different from the Expert Panel's data sources needed to determine that biopersistence. Thus, while the Expert Panel considered in vitro data to as an appropriate surrogate for biopersistence, the NTP in the 12th RoC ultimately rejected in vitro data instead looked to animal assessments -in vivo data -to determine biopersistence and hence hazard. Based on the 12th RoC documentation and the Expert Panel's recommendations used to support the fiber glass listing, it would appear that the adjective -''Certain'' refers to -''Inhalable Biopersistent Glass Fibers.'' For clarity, it would have been helpful if the 12th RoC had explicitly stated -''Less Biopersistent Glass Fibers'' are not listed as ''reasonably anticipated to be a human carcinogen'' or ''a human carcinogen'' in keeping with the recommendation of the Expert Panel.
The shift from the use of ''respirable'' to ''inhalable'' deserves discussion. This is a subtle change likely to be of little consequence for any specific glass fibers with regard to its inclusion or exclusion under the descriptor -''Certain Glass Wool Fibers.'' The terms are relevant in describing qualitative differences in the likelihood of fibers reaching various compartments of the respiratory tract. It is important to recognize that neither term, respirable or inhalable, addresses the solubility and, hence, the biopersistent of glass fibers. The American Conference on Governmental Industrial Hygienists (ACGIH) provided one of the earliest and clearest description of inhalable versus respirable particles consistent with recognition that fibers are a special kind of particle (ACGIH 1997 (ACGIH , 2011 . Inhalable Particulate Matter, characterized as to their aerodynamic diameter, is used for those ''materials that are hazardous when deposited anywhere in the respiratory tract.'' In contrast, respirable particulate matter, is used ''for those materials that are hazardous when deposited in the gas-exchange region.'' In reality, all inhalable particles include a respirable fraction and rarely is an aerosol characterized as inhalable free of respirable particles. Thus, neither the use of ''respirable'' or ''inhalable'' is particularly constraining on fibers covered with the descriptor -''Certain Glass Wool Fibers.''
California Office of Environmental Health Hazard Assessment
It is noteworthy that the California Office of Environmental Health Hazard Assessment (OEHHA) published on November 18, 2011, a Notice of Modification of the Listing of Glasswool Fibers (Airborne Particles of Respirable Size) to ''Glass Wool Fibers (Inhalable and Biopersistent)'' OEHHA in 1990 had listed ''glass wool fibers (airborne particles of respirable size) as known to the State to cause cancer via the authoritative bodies listing mechanism.'' This determination was based on the IARC (1988) monograph. This listing was further substantiated by the Seventh Annual Report on Carcinogens (NTP, 1994) listing of ''glass wool (respirable size) as reasonably anticipated to be a human carcinogen. The 12th Report on Carcinogens (NTP, 2011a,b) listing of ''Certain Glass Wool Fibers (Inhalable) as reasonably anticipated to be carcinogenic to humans'' prompted the California OEHAA to modify its listing. Effective November 18, 2011, the listing is ''Glass Wool fibers (inhalable and biopersistent).'' The specific inclusion of ''biopersistent'' in the listing language, along with ''inhalable,'' provides a very explicit and concise statement that is consistent with the scientific evidence. Most notably, it is less ambiguous than the NTP listing that did not clearly identify biopersistence as being crucial in determining the carcinogenic potential of glass wool fibers.
''Green'' products and technologies
It is of interest to consider the NTP's actions with regard to the classification of ''Certain Glass Wool Fibers (Inhalable)'' within the broader context of NTP's future actions classifying other ''green products and technologies.'' Here we use the term ''green products or technologies'' as an umbrella term for new products or technologies that are intended to have reduced impact on the environment and human health'' as compared to the product or technology being replaced or reduced in use.
These ''green products or technologies,'' including newly developed low biopersistent glass wool fibers, pose a special challenge for those charged with classifying a new substance as to its potential human health hazards including carcinogenicity. At the outset, it is important to recognize that evaluating the hazard of a new product or technology is very different than evaluating a specific chemical. A chemical is the same at all times, benzene or formaldehyde today is the same as the chemical was a decade or a century ago. The uses of a chemical may change over time but its basic physical properties do not change. Knowledge of the hazard of the chemical may change over time as a result of additional research and advances in science. Thus, evidence of the potential hazard of the chemical is germane whether it was obtained last year or a half century ago. That is not true for a product or technology that has been purposefully changed. It is apparent in developing the 12th RoC listing for glass fibers, the NTP struggled with differentiating between information gained from studies conducted decades ago with old materials versus that obtained on contemporary materials.
As an aside, the RoC listings published to date have dealt almost exclusively with specific chemicals. Of 54 Substances listed in the 12th RoC as ''Known to be Human Carcinogens'' only a few are not specific chemicals and, thus, have the potential to change with new technological developments. Of the 188 Substances listed in the 12th RoC as ''reasonably anticipated to be a human carcinogen'' only three substances are likely to have their principal characteristics changed as a result of purposeful new technological advances: (a) Ceramic Fibers (Respirable Size), (b) Diesel Exhaust Particulates and (c) Certain Glass Wool Fibers (Inhalable). The development of safer glass fibers has been addressed in this paper. Ceramic fibers without carcinogenic properties have already been developed. Revolutionary technological changes have been made in diesel engines such that with use of ultra-low sulfur fuels and exhaust after treatment emissions from New Technology Diesel Engines are less than 1% of the emissions of Tradition Diesel Engines (Hesterberg et al., 2011) .
A second issue was noted by the IARC Working Group (IARC, 2002a) for the less biopersistent glass wool fibers, ''no human data were available.'' The newly developed products have been produced and on the market for only a few years. Thus, epidemiological studies focusing on late-occurring diseases such as cancer of production workers or users of the new products are not feasible soon after a product has been introduced. Even with the passage of time, such studies are not likely to be conducted if the product is viewed as having a low hazard potential. Grandjean et al. (2011) , based on a review of over 100,000 journal articles published in 2000-2009, noted that ''the persistence of some environmental chemicals in the scientific literature may be due to a ''Mathew'' principle of maintaining prominence for the very reason of having been well researched.'' It follows then that research will continue to be performed on well-studied Traditional Diesel Exhaust with limited studies conducted on New Technology Diesel Exhaust. The low likelihood of detecting positive effects in studies with New Technology Diesel Exhaust is likely to serve as a detriment to conducting such studies.
The absence of human evidence for a new ''green product or technology'' places a premium on the development of other data that may be predictive of hazard potential. The short-term in vitro and in vivo biopersistence studies for glass fibers provide that kind of predictive information. The Glass Wool Fiber Expert Panel (Kelsey et al., 2009a,b) recognized that with their recommendations. The 12th RoC documentation (NTP, 2011a,b) for ''Certain Glass Wool Fibers (Inhalable)'' contains the statement -''Because there is considerable variation in the physiochemical and biological properties of individual glass wool fibers, carcinogenic potential must be assessed on a case-by-case basis in experimental animals, through either long-term carcinogenicity assays, or assays measuring the persistence of fibers in the lung.'' This statement is essentially an endorsement of the predictive capability of the shortterm biopersistence assays for characterizing synthetic vitreous fibers as to their carcinogenic potential, an approach that reduces the need to conduct laboratory animal studies. As already noted, animal carcinogenicity bioassays are expensive, time consuming and required the use of large numbers of laboratory animals.
Summary and conclusions
This paper has reviewed a proactive product stewardship approach developed by J-M, working in partnership with other glass fiber manufacturers, in response to the product liability crisis that arose over whether glass fibers would be the next asbestos. A central component of the approach was an extensive testing and research program to assure that fiber glass products were safe to manufacture and use. As of the mid 1980s, the state of the science in fiber toxicology was not well developed. Different approaches used to evaluate the toxicity of fibers produced seemingly contradictory results. A comprehensive, systematic and scientific approach was needed. J-M, in cooperation with other manufacturers of fiber glass designed, contracted for, and in some cases, directly conducted epidemiological studies, animal toxicology investigations and in vitro studies. The epidemiology studies included production and maintenance workers at 17 of the oldest and largest fiber glass and mineral wool manufacturing facilities in the United States. Those studies reaffirmed the lack of association between exposure to glass wool fibers and respiratory tract cancer.
There were numerous difficulties interpreting the results of early research on glass fibers and other inorganic fibers conducted in laboratory animals. As noted, these studies often used non-physiological exposure routes such as intraperitoneal, intrapleural, or intratracheal injection of massive quantities of fibers. New studies were designed and conducted that systematically addressed these limitations and provided data that was more relevant for assessing the potential human health hazards of exposure to airborne fibers. The chronic inhalation exposure studies conducted in rats and Syrian hamsters demonstrated that biopersistence was the key determinant of the toxicity and carcinogenicity of synthetic vitreous fibers. As expected, Amosite and Crocidolite Asbestos, which were very persistent in the lungs, produced lung fibrosis and tumors. Glass wool, Rock (Stone) Wool and Slag Wool Fibers, which had low biopersistence in the lungs did not cause lung fibrosis or tumors, while the more durable and biopersistent man-made fibers (an industrial refractory ceramic fiber and a special purpose fiber) caused increased incidences of fibrosis and tumors. Fiber clearance rates determined from short-term inhalation studies were found to correlate very well with fiber induced pathology with biopersistent fibers producing pathological changes in the respiratory tract. An understanding of the determinants of toxicity and carcinogenicity has provided a scientific basis for developing and introducing new safer fiber glass products. The availability of short-term test methods for evaluating biopersistence has greatly facilitated development of safer new glass fibers.
An important finding was that the results of in vitro cell culture studies were not predictive of the fibrosis and tumor induction observed in the chronic rodent inhalation studies with less biopersistent fibers. This evaluation indicated that the in vitro cell culture models generated false positive results presumably related to the large doses of fibers used in the assays. It is clear that the results of past cell culture studies with large doses of fibers should not be considered valid for assessing human health hazards, and most certainly not risks, from SVFs. In contrast, the results of in vitro fiber dissolution studies which measure fiber dissolution and breakage in simulated biological fluids in the absence of cells were good predictors of the in vivo fate of fibers in the rodent inhalation biopersistence studies and the occurrence of fibrosis and tumors.
The experience with synthetic fibers provides important perspective for the growing enthusiasm for using short-term test methods based on modern biology to evaluate the potential toxicity of chemicals and other agents (NRC, 2007) . At least two important lessons emerge from the synthetic fiber experience. First, realistic doses of fibers that can be linked to realistic exposure conditions must be selected for evaluation in in vitro assays. Unrealistic doses administered to cells can yield results that on superficial examination appear mechanistically plausible. The development of mechanistic data with high levels of in vitro exposure does not necessarily mean the observed mechanisms are likely to occur with lower levels of exposure and tissue doses likely to be encountered by workers or the general public. Second, it is important that tests, whether they be in vitro assays such as those used to evaluate mutagenicity, short-term animal tests to evaluate biopersistence or chronic animal bioassays to evaluate carcinogenicity, need to be evaluated for their predictive capability using both materials known to be human toxicants and materials demonstrated to have an absence of human toxicity. In the case of asbestos and other fibers, the endpoint of concern was the potential for inducing respiratory tract cancer. A large body of evidence clearly indicated certain kinds of asbestos are carcinogenic to humans. For certain kinds of SVFs, a convincing body of epidemiological evidence was available showing that exposure to glass fibers do not have an associated increase in respiratory tract cancers. This human data, both positive and negative, were of immense importance in validating the predictive capability of the chronic inhalation bioassay protocol and the short-term biopersistence protocol. Most importantly, it is now clear that what once were thought to be biologically plausible predictions of human hazards for glass fibers were not valid.
By the turn of the 21st century, the state of the science in fiber toxicology had progressed from a tangle of contradictory theories to clear understanding of the behavior of fibers in the lung. In vitro studies, and even chemistry models based on those studies, can now be used to predict the biopersistence of fibers in well-designed and well-conducted animal studies. Most importantly, these advances in the science provide a basis for understanding which synthetic fibers have the potential for producing disease or mortality and conversely, the fibers with limited hazard potential.
One result of this proactive product stewardship approach to sponsoring scientific research that yielded new information on the potential health effects of SVFs was the reclassification by IARC of Glass Wool, Rock (Stone) Wool and Slag Wool fibers from ''possibly carcinogenic to humans (Group 2B) to ''not classifiable as to their carcinogenicity to humans (Group 3).'' The National Toxicology Program's Report on Carcinogens, used the same extensive body of information to conclude -''Certain Glass Wool Fibers (Inhalable)'' -''reasonably anticipated to be a human carcinogen.'' In our view, the descriptor -''Certain Glass Wool Fibers (Inhalable)'' may be viewed as equivalent to ''Inhalable Biopersistent Glass Fibers'' with purposeful exclusion of biosoluble and, thus, less biopersistent, glass fibers. This approach is consistent with the California OEHHA approach of listing ''Glass Wool Fibers (Inhalable and Biopersistent)'' ''as reasonably anticipated to be a human carcinogen.''
The most significant outcome of this substantial product stewardship effort is that industry has used the research results to guide changes in the composition of fibers and the manufacturing process. This has resulted in glass fiber products marketed today that are even less biopersistent than earlier fiber glass product, if inhaled, and, thus, can be viewed as safer. Public confidence in the safety of fiber glass used as an insulating material is especially important in today's economy that emphasizes energy efficiency.
Dedication -Dr. Paul Kotin
The authors dedicate this manuscript to the memory of Dr. Paul Kotin (1917 Kotin ( -2008 . Dr. Kotin was a pioneer in the field of occupational and environmental health. He received his M.D. from the University of Illinois in 1939. After completing a residency in Pathology at Deaconess Hospital in Chicago, he served in the US Army Medical Corps from 1941 to 1946 followed by several years of private practice. In 1948, he joined the faculty of the University of Southern California. In 1962, he moved his research program on the health effects of air pollution from the University of Southern California to the National Cancer Institute in Bethesda, MD. Kotin was to ultimately serve as Scientific Director for Etiology, National Cancer Institute. In that role he was a visionary as evidenced by a letter he wrote to Mary W. Lasker, Albert and Mary Lasker Foundation, following a meeting with her concerning research on carcinogenesis. He wrote on April l8, 1966 -''Attached is a brief description of six research activities which I believe are ready for exploitation. You will note that they are directed to and primarily emphasize the use of human populations for the study of cancer in man with appropriate supporting laboratory-experimental studies. I believe that recent advances in both areas have provided a firm base for expansion of research in which both approaches can be simultaneously pursued in a cooperative and complementary manner. This inter-digitation of the experimental laboratory and the human population laboratory to the end of increasing the effectiveness of our cancer control efforts offer hope of significantly shortening the time when we may see demonstrable benefits as measured by improved morbidity and mortality data.'' The letter and attachment is available on-line within ''The Mary Lasker papers, Profiles in Science, National Library of Medicine.'' The vision he outlined in 1966 remains appropriate today. Ironically, in that letter one of the populations he identifies as needing further study are those engaged in ''asbestos mining and use.'' In his 1966 letter, he suggested a need for additional funds of $9 million in 1967 growing to $25 million in 1970. In November 1966, he was named as Head of what was then called the National Institutes of Health (NIH) Division of Environmental Health Sciences. In 1969, the Division became the nucleus of the National Institute for Environmental Health Sciences, the ninth NIH Institute with an initial budget of $17.8 million. Kotin was named the Institute's first Director.
In 1971, he became Dean of the School of Medicine, Vice President for Health Science and Provost at Temple University, Philadelphia, PA where he had substantial impact on that institution's Medical School.
In 1974, Kotin joined J-M as Senior Vice President for Health, Safety and Environment. Kotin was with J-M during the difficult time period when the asbestos issue came to the forefront and forced J-M into bankruptcy. He recognized the importance of J-M emerging from bankruptcy as a viable corporation if it was going to provide financial compensation to individuals who had asbestos exposure-related diseases. This, in turn, led to his fervent support of the research program to ensure that the fiber glass products manufactured and marketed by J-M were safe. It is not surprising that the J-M research program on glass fibers fostered by Kotin included both human population and laboratory-experimental studies with both kinds of studies simultaneously pursued in a cooperative and complementary manner. The continued availability of safe fiber glass products for use around the world is a tribute to the vision of Paul Kotin.
